Companies will investigate targets that historically have been a challenge for therapeutic development More: Janssen and Immune Bioscience team up for oncology antibodies Source: News
read moreCompanies will leverage each others technology platforms against six initial targets More: Regeneron and Bluebird Bio collaborate on T-cells in 0 million deal Source: News
read moreCollaboration also includes UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations, and Oxford BioMedica More: Boehringer joins consortium to develop new cystic fibrosis gene therapies Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals